CloroxPro Blog
    Healthcare

The New EVS Landscape: Costs, Technology & Smart Cleaning in 2026

Healthcare facilities continue to navigate significant challenges, including tightened budgets for environmental services (EVS), reduced staffing, changing facility funding structures and technology, all while managing increased demands from patients and staff. In talking with leaders in environmental services (EVS) across the country, I saw these same themes arise repeatedly in 2025, including shared challenges and exciting innovations that are and will change how we work.

A hospital worker wiping down a table in a hospital room

In 2026, the EVS mandate is clear: Do more with less and do it with fewer errors, more transparency and measurable impact. Success will hinge on three levers: product choices, workflow simplification and targeted technology that removes friction rather than adding it.

Reusable microfiber cloths vs. disposable wipes: balancing performance, cost and efficiency

One topic that continues to generate significant discussion is determining the right disinfectant wipe for your EVS cleaning program: reusable microfiber cloths or ready-to-use (RTU) disposable wipes. There isn’t a one‑size‑fits‑all answer.

Reusable microfiber cloths paired with dilutable disinfectants have been utilized for many years and have some strong advantages, including durability, excellent soil-removal performance and generally good chemical compatibility. However, the initial investment can be substantial and costly, with many hidden costs, especially when using a full rental service. If laundering is done in-house, facilities must have the proper equipment, plenty of stock on hand and validated laundering processes, as reusable microfiber will degrade over time. Additionally, if textiles are not processed correctly between uses, there is an increased risk of cross-contamination, which can reintroduce pathogens into the patient care environment.

On the other hand, disposable RTU wipes offer several advantages. Because each wipe is single-use, the risk of cross-contamination is significantly reduced. Performance and contact time compliance is consistent since staff are always using a new product, and there is no laundering required, eliminating water and energy consumption as well as associated costs. Disposable RTU wipes are also lightweight and easier for staff to transport. However, the raw materials used to manufacture disposable microfiber can fluctuate in availability and cost, leading to inconsistent pricing. Quality can also fluctuate among manufacturers, which may lead to inconsistent performance. Standardizing on a labeled, healthcare-grade RTU across units can reduce training complexity and variability, but supply chain reliability and price stability should be assessed in contracting.

Both reusable microfiber and disposable wipes are viable options, but the stronger candidate for your facility ultimately depends on what aligns best with the needs, goals and resources of your cleaning program.

Ready-to-use (RTU) disinfectants in practice

RTU disinfectants can simplify workflows by eliminating on‑site dilution, reducing error risk, and supporting consistent contact‑time compliance. Solutions like Clorox Healthcare Bleach Germicidal Disinfectants offer predictable performance for high‑risk settings without the infrastructure demands of reprocessing. The key is to right‑size chemistry to the task and surface (efficacy needs, material compatibility and staff usability).

AI and robotics: smart integration for the future of cleaning programs

As EVS departments struggle to increase, or even maintain, their staff due to ongoing financial pressures, AI and autonomous robots will likely play an increasingly crucial role in supporting daily operations. AI and robotics continue to transform the healthcare industry as a whole, with the market projected to reach a total value of $491 billion by the end of 2027.1 Tasks such as scrubbing floors can be automated, allowing teams to reallocate those saved labor hours to other high-priority needs across the facility, such as discharge room cleaning or enhanced detail work. Beyond cleaning-related use cases, AI holds significant opportunity for infection prevention, particularly in the identification of Healthcare Associated Infections (HAIs).2 While human oversight is critical, AI-enabled HAI surveillance could unlock new ways for infection preventionists to partner with EVS. These capabilities may help pinpoint facility-specific opportunities for enhanced cleaning and disinfection, deliver actionable, facility-wide outcome data and support predictive analytics to better align EVS staffing with infection risk.

2026 and beyond

With all the innovations we’ve seen in 2025, it’s clear that EVS is not only accelerating, but that we are redefining the standards of care across the industry. As our field continues to innovate, we are raising standards at an unprecedented pace.

As we continue in 2026, it’s no longer a question of if change will happen, but how quickly we can adapt to lead it and continue to grow. EVS professionals are uniquely positioned to lead the next wave of innovation by driving safer environments, smarter workflows and stronger partnerships across the care continuum.

Share this article

About the Author

Profile image of James E. Odom, Jr. (J.J.), MBA, CHESP, CMIP, T-CHEST
University Director of Buildings & Grounds, UConn Health
J.J. currently serves as the University Director of Buildings & Grounds at UConn Health in Farmington, Connecticut. With 38 years of experience in the health care industry, he began his career in frontline roles before quickly advancing into leadership, where he has served at the director level for more than 33 years. An active and dedicated member of the Association for the Health Care Environment (AHE), J.J. has contributed to numerous committees, including the Advisory Council, Exchange Planning, Nomination, and Knowledge & Education Committees. He also served six years as an at-large board member and one year as President of the AHE New England Chapter. Since 2025, J.J. currently serves as an at-large board member of the AHE Advisory Board and was elected Chair-Elect for the 2026–2028 term. He will assume the role of Advisory Board Chair beginning January 2028.

More from the Clorox Pro Blog

    References

    1. World Economic Forum. The Future of AI-Enabled Health [internet]. 2025 [cited on January 5, 2026]. Available from: https://reports.weforum.org/docs/WEF_The_Future_of_AI_Enabled_Health_2025.pdf
    2. 2 Wiemken TL, Carrico RM. Assisting the infection preventionist: Use of artificial intelligence for health care-associated infection surveillance. Am J Infect Control [internet]. 2024 [cited on April 1, 2024]. Available from: https://pubmed.ncbi.nlm.nih.gov/38483430/